🎉 M&A multiples are live!
Check it out!

Sikarin Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sikarin and similar public comparables like Integral Diagnostics, Compass Pathways, and PureHealth.

Sikarin Overview

About Sikarin

Sikarin PCL is a Thailand-based company operating in the healthcare sector. It operates private hospitals located in eastern Bangkok, Samutprakarn Province and Hat Yai District, Songkhla Province namely Sikarin Hospital, Sikarin Samut Prakan Hospital, and Sikarin Hat Yai Hospital. Its services include general surgery services, obstetrics, aesthetic center, dental center, orthopedic center, checkup center, emergency and trauma center, and children center, among others.


Founded

1994

HQ

Thailand
Employees

3.0K+

Website

sikarin.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$421M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Sikarin Financials

Sikarin has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Sikarin achieved revenue of $178M and an EBITDA of $42.0M.

Sikarin expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Sikarin valuation multiples based on analyst estimates

Sikarin P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $171M $178M XXX XXX XXX
Gross Profit $59.8M $58.8M XXX XXX XXX
Gross Margin 35% 33% XXX XXX XXX
EBITDA $48.8M $42.0M XXX XXX XXX
EBITDA Margin 29% 24% XXX XXX XXX
Net Profit $29.7M $26.2M XXX XXX XXX
Net Margin 17% 15% XXX XXX XXX
Net Debt n/a $1.1M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Sikarin Stock Performance

As of April 15, 2025, Sikarin's stock price is THB 7 (or $0).

Sikarin has current market cap of THB 14.7B (or $432M), and EV of THB 14.3B (or $421M).

See Sikarin trading valuation data

Sikarin Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$421M $432M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Sikarin Valuation Multiples

As of April 15, 2025, Sikarin has market cap of $432M and EV of $421M.

Sikarin's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Sikarin's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Sikarin and 10K+ public comps

Sikarin Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $421M XXX XXX XXX
EV/Revenue 2.4x XXX XXX XXX
EV/EBITDA 10.0x XXX XXX XXX
P/E 22.2x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 15.9x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Sikarin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Sikarin Valuation Multiples

Sikarin's NTM/LTM revenue growth is n/a

Sikarin's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $9K for the same period.

Over next 12 months, Sikarin's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Sikarin's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Sikarin and other 10K+ public comps

Sikarin Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 4% XXX XXX XXX XXX
EBITDA Margin 24% XXX XXX XXX XXX
EBITDA Growth -14% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.1M XXX XXX XXX XXX
Opex per Employee $9K XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue 15% XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 15% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Sikarin Public Comps

See public comps and valuation multiples for Hospitals & Clinics comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Burjeel Holdings XXX XXX XXX XXX XXX XXX
PureHealth XXX XXX XXX XXX XXX XXX
Integral Diagnostics XXX XXX XXX XXX XXX XXX
Ramsay Health XXX XXX XXX XXX XXX XXX
Compass Pathways XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Sikarin M&A and Investment Activity

Sikarin acquired  XXX companies to date.

Last acquisition by Sikarin was  XXXXXXXX, XXXXX XXXXX XXXXXX . Sikarin acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Sikarin

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Sikarin

When was Sikarin founded? Sikarin was founded in 1994.
Where is Sikarin headquartered? Sikarin is headquartered in Thailand.
How many employees does Sikarin have? As of today, Sikarin has 3.0K+ employees.
Is Sikarin publicy listed? Yes, Sikarin is a public company listed on BKK.
What is the stock symbol of Sikarin? Sikarin trades under SKR ticker.
When did Sikarin go public? Sikarin went public in 1988.
Who are competitors of Sikarin? Similar companies to Sikarin include e.g. Burjeel Holdings, PureHealth, Integral Diagnostics, Ramsay Health.
What is the current market cap of Sikarin? Sikarin's current market cap is $432M
What is the current revenue growth of Sikarin? Sikarin revenue growth between 2023 and 2024 was 4%.
Is Sikarin profitable? Yes, Sikarin is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.